Kezar Life Sciences, Inc. (KZR)
7.29
0.00 (0.00%)
USD |
NASDAQ |
May 29, 16:00
Kezar Life Sciences Shareholders Equity (Quarterly) : 65.24M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| NovelStem International Corp. | -1.947M |
| Brainstorm Cell Therapeutics, Inc. | -11.01M |
| Summit Therapeutics, Inc. | 545.93M |
| Protara Therapeutics, Inc. | 181.21M |
| Clene, Inc. | -18.81M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 68.00M |
| Total Liabilities (Quarterly) | 2.762M |
| Debt to Equity Ratio | 0.0208 |
| Current Ratio | 24.46 |
| Net Debt Paydown Yield | 5.42% |